Guru Ownership Trend
Guru Analysis for Rocket Pharmaceuticals, Inc. (RCKT)
Rocket Pharmaceuticals, Inc. (RCKT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $21.41 M.
Top institutional holders include Lee Ainslie and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.67 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 17.1%. Conversely, Steven Cohen reduced exposure by 33.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Rocket Pharmaceuticals, Inc. (RCKT)
Major holders include Lee Ainslie ($13.42 M), Cliff Asness ($11.58 M), Renaissance Technologies (RenTech) ($2.44 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 8.96 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.67 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited RCKT. The total reported sell value was $1.17 M.
Yes, 0 managers opened new positions in RCKT, and 3 increased their existing holdings. The total reported buy value was $2.83 M.